-
1دورية أكاديمية
المؤلفون: Linda Ben Saïd, Laure Diancourt, Audrey Rabeau, Virginie Gallet, Gauthier Delvallez, Marion Grare
المصدر: Microorganisms, Vol 12, Iss 6, p 1095 (2024)
مصطلحات موضوعية: Clostridium perfringens, binary enterotoxin, BEC, blood culture, human infection, Biology (General), QH301-705.5
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Corentin Pasquier, Léonor Chaltiel, Carole Massabeau, Audrey Rabeau, Louisiane Lebas, Amélie Lusque, Jean-Sébastien Texier, Elizabeth Cohen-Jonathan Moyal, Julien Mazières, Jonathan Khalifa
المصدر: Frontiers in Oncology, Vol 13 (2023)
مصطلحات موضوعية: radiotherapy, immunotherapy, non-small cell lung cancer (NSCLC), tumor-draining lymph nodes (TDLN), EDRIC, lymphopenia, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2023.1186479/fullTest; https://doaj.org/toc/2234-943XTest
-
3دورية أكاديمية
المؤلفون: Capucine Baldini, Francois-Xavier Danlos, Aurélien Marabelle, Jean-Charles Soria, Christophe Massard, Lydie Cassard, Julien Adam, David Planchard, Andreea Varga, Gérard Zalcman, Nathalie Chaput-Gras, Matthieu Texier, Severine Mouraud, Bastien Job, Diane Letourneur, Delphine Bredel, Salim Laghouati, Nathalie Droin, Aurelien Parpaleix, Audrey Rabeau
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2051-1426Test
-
4دورية أكاديمية
المؤلفون: Fabrice Barlesi, Adrien Dixmier, Didier Debieuvre, Christophe Raspaud, Jean-Bernard Auliac, Nicolas Benoit, Pierre Bombaron, Denis Moro-Sibilot, Clarisse Audigier-Valette, Bernard Asselain, Thomas Egenod, Audrey Rabeau, Jérôme Fayette, Myriam Locatelli Sanchez, Jean-Luc Labourey, Virginie Westeel, Pauline Lamoureux, François-Emery Cotte, Victoria Allan, Melinda Daumont, Juliette Dumanoir, Dorothée Reynaud, Christophe Yannick Calvet, Nicolas Ozan, Maurice Pérol
المصدر: OncoImmunology, Vol 9, Iss 1 (2020)
مصطلحات موضوعية: evidens, france, nivolumab, non-small cell lung cancer, observational study, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2162-402XTest
-
5دورية أكاديمية
المؤلفون: Guillaume Herbreteau, Alexandra Langlais, Laurent Greillier, Clarisse Audigier-Valette, Lionel Uwer, José Hureaux, Denis Moro-Sibilot, Florian Guisier, Delphine Carmier, Jeannick Madelaine, Josiane Otto, Pierre-Jean Souquet, Valérie Gounant, Patrick Merle, Olivier Molinier, Aldo Renault, Audrey Rabeau, Franck Morin, Marc G Denis, Jean-Louis Pujol
المصدر: Journal of Clinical Medicine, Vol 9, Iss 12, p 3861 (2020)
وصف الملف: electronic resource
-
6
المؤلفون: Corentin Pasquier, Léonor Chaltiel, Carole Massabeau, Audrey Rabeau, Louisiane Lebas, Amélie Lusque, Jean-Sébastien Texier, Elizabeth Cohen-Jonathan Moyal, Julien Mazières, Jonathan Khalifa
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, radiotherapy, immunotherapy, non-small cell lung cancer (NSCLC), tumor-draining lymph nodes (TDLN), EDRIC, lymphopenia, elective node irradiation
الإتاحة: https://doi.org/10.3389/fonc.2023.1186479.s001Test
https://figshare.com/articles/dataset/Table_1_Impact_of_radiation_on_host_immune_system_in_patients_treated_with_chemoradiotherapy_and_durvalumab_consolidation_for_unresectable_locally_advanced_non-small_cell_lung_cancer_docx/23530236Test -
7
المؤلفون: Cécile Le Péchoux, Anne-Marie C. Dingemans, Laura Mezquita, Boris Duchemann, Emmanuèle Lechapt, Clarisse Audigier-Valette, Clemence Henon, Sophie Cousin, Lizza E.L. Hendriks, Samy Ammari, David Planchard, Anas Gazzah, Corentin Lefebvre, Caroline Caramella, Dirk De Ruysscher, Roberto Ferrara, Julien Mazieres, Angela Botticella, Edouard Auclin, Julien Adam, Audrey Rabeau, Sylvestre Le Moulec, Benjamin Besse
المساهمون: Pulmonologie, Promovendi ODB, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie
المصدر: Journal of Thoracic Oncology, 14(7), 1244-1254. Elsevier Science
مصطلحات موضوعية: 0301 basic medicine, Male, Lung Neoplasms, Programmed Cell Death 1 Receptor, Pembrolizumab, NSCLC, Gastroenterology, B7-H1 Antigen, 0302 clinical medicine, Antineoplastic Agents, Immunological, Disease specific Graded Prognostic Assessment, Carcinoma, Non-Small-Cell Lung, Checkpoint inhibition, Medicine, Aged, 80 and over, DOCETAXEL, Brain Neoplasms, Middle Aged, Prognosis, OPEN-LABEL, Survival Rate, Oncology, Docetaxel, 030220 oncology & carcinogenesis, Cohort, Carcinoma, Squamous Cell, Female, Nivolumab, medicine.drug, Pulmonary and Respiratory Medicine, Adult, medicine.medical_specialty, Adenocarcinoma of Lung, survival, 03 medical and health sciences, Internal medicine, PATIENTS PTS, Humans, Lung cancer, PEMBROLIZUMAB, Pseudoprogression, Aged, Retrospective Studies, business.industry, Proportional hazards model, NIVOLUMAB, Brain metastases, medicine.disease, EFFICACY, Confidence interval, LIFE, 030104 developmental biology, business, SYSTEM, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f71577960fdcb3b6db9e0ec054f54aa9Test
https://doi.org/10.1016/j.jtho.2019.02.009Test -
8
المؤلفون: Valérie Gounant, Delphine Carmier, Alexandra Langlais, Lionel Uwer, Denis Moro-Sibilot, Franck Morin, Olivier Molinier, José Hureaux, Pierre-Jean Souquet, Patrick Merle, Jean-Louis Pujol, Sébastien Bommart, Clarisse Audigier-Valette, Pierre Mourlanette, Florian Guisier, Aldo Renault, Martine Antoine, Jeannick Madelaine, Laurent Greillier, Marc G. Denis, Audrey Rabeau, J. Otto
المساهمون: Equipe Quantification en Imagerie Fonctionnelle (QuantIF-LITIS), Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Université Le Havre Normandie (ULH), Normandie Université (NU)-Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Normandie Université (NU)
المصدر: Journal of Thoracic Oncology
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2019, 14 (5), pp.903-913. ⟨10.1016/j.jtho.2019.01.008⟩مصطلحات موضوعية: Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Randomization, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Phases of clinical research, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, medicine, Clinical endpoint, Chemotherapy, Humans, Aged, Aged, 80 and over, Programmed cell death ligand 1, business.industry, SCLC, Middle Aged, Small Cell Lung Carcinoma, Confidence interval, 3. Good health, 030104 developmental biology, 030220 oncology & carcinogenesis, Toxicity, Female, Topotecan, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0f0c334a072ea9fa844d16554706157Test
https://doi.org/10.1016/j.jtho.2019.01.008Test -
9
المؤلفون: Pauline Lamoureux, Denis Moro-Sibilot, Thomas Egenod, P. Bombaron, Melinda Daumont, Audrey Rabeau, Adrien Dixmier, Christophe Raspaud, Nicolas Benoit, Didier Debieuvre, N. Ozan, Juliette Dumanoir, Bernard Asselain, Virginie Westeel, C. Calvet, Clarisse Audigier-Valette, Dorothee Reynaud, Victoria Allan, Fabrice Barlesi, François-Emery Cotté, Maurice Pérol, Jean-Bernard Auliac, Jérôme Fayette, Jean-Luc Labourey, Myriam Locatelli Sanchez
المصدر: Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, medicine.medical_specialty, Lung Neoplasms, Immunology, Treatment of lung cancer, EVIDENS, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Immunology and Allergy, Humans, Prospective Studies, Lung cancer, RC254-282, non-small cell lung cancer, nivolumab, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC581-607, medicine.disease, 030104 developmental biology, 030220 oncology & carcinogenesis, Observational study, observational study, France, Immunologic diseases. Allergy, Nivolumab, business, Back Matter
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3aa8e4cd6d1d9936466474b2b2ea83Test
https://pubmed.ncbi.nlm.nih.gov/33457089Test -
10
المؤلفون: Denis Moro-Sibilot, Guillaume Herbreteau, Olivier Molinier, José Hureaux, Patrick Merle, Jeannick Madelaine, Audrey Rabeau, J. Otto, Florian Guisier, Clarisse Audigier-Valette, Lionel Uwer, Valérie Gounant, Aldo Renault, Marc G. Denis, Laurent Greillier, Jean-Louis Pujol, Alexandra Langlais, Franck Morin, Pierre-Jean Souquet, Delphine Carmier
المساهمون: Centre hospitalier universitaire de Nantes (CHU Nantes), Intergroupe Francophone de Cancérologie Thoracique [Paris] (IFCT), Intergroupe Francophone de Cancérologie thoracique, Assistance Publique - Hôpitaux de Marseille (APHM), Centre Hospitalier Intercommunal Toulon-La Seyne sur Mer - Hôpital Sainte-Musse, Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), UNICANCER, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), CHU Grenoble, Service de pneumologie, oncologie thoracique et soins intensifs respiratoires [Rouen], Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Hôpital Charles Nicolle [Rouen]-CHU Rouen, Normandie Université (NU), Hôpital Bretonneau, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Service de pneumologie [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Service de pneumologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Service d’oncologie thoracique et essais précoces [CHU Bichat], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Clermont-Ferrand, Centre Hospitalier Le Mans (CH Le Mans), Centre hospitalier de Pau, Service de pneumologie [Toulouse], CHU Toulouse [Toulouse]-Hôpital Larrey [Toulouse], CHU Toulouse [Toulouse], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Herrada, Anthony, Hôpital Charles Nicolle [Rouen]-CHU Rouen
المصدر: Journal of Clinical Medicine
Journal of Clinical Medicine, MDPI, 2020, 9 (12), pp.3861. ⟨10.3390/jcm9123861⟩
Journal of Clinical Medicine, Vol 9, Iss 3861, p 3861 (2020)
Journal of Clinical Medicine, 2020, 9 (12), pp.3861. ⟨10.3390/jcm9123861⟩
Volume 9
Issue 12مصطلحات موضوعية: Oncology, atezolizumab, medicine.medical_specialty, medicine.medical_treatment, lcsh:Medicine, [SDV.CAN]Life Sciences [q-bio]/Cancer, medicine.disease_cause, Article, 03 medical and health sciences, 0302 clinical medicine, Germline mutation, [SDV.CAN] Life Sciences [q-bio]/Cancer, Atezolizumab, Internal medicine, medicine, RB1, Progression-free survival, TP53, 030304 developmental biology, 0303 health sciences, Chemotherapy, Mutation, business.industry, lcsh:R, SCLC, General Medicine, Immunotherapy, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, ctDNA, NOTCH, 3. Good health, Clinical trial, 030220 oncology & carcinogenesis, Non small cell, [SDV.IMM.IMM] Life Sciences [q-bio]/Immunology/Immunotherapy, mutation, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c50a707dbfc16b1eab6bacdf79ed4426Test
http://europepmc.org/articles/PMC7760916Test